Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid

Anticancer Research

Volumn 20, Issue 4, 2000, Pages 2653-2658

  Rafi, Mohamed M ^a,b   Rosen, Robert T ^d   Vassil, Andrew ^b   Ho, Chi Tang ^d   Zhang, Huayan ^a,c   Ghai, Geetha ^d   Lambert, George ^a,b,c   DiPaola, Robert S ^a,b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c Enviommental and Occupational Health Sciences Institute   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

bcl 2; Chalcone; Flavonoid; Licochalcone A; Phytoestrogen

Indexed keywords

CHALCONE; FLAVONOID; LICOCHALCONE A; PACLITAXEL; PHYTOESTROGEN; PROTEIN BCL 2; VINBLASTINE;

ACUTE LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASSAY; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN HL 60; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; ESTROGEN ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CHALCONE; CHALCONES; ESTROGENS, NON-STEROIDAL; HUMANS; ISOFLAVONES; PHYTOESTROGENS; PLANT PREPARATIONS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; YEASTS;

EID: 0033861361     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Knight DC and Eden JA: A review of the clinical effects of phytoestrogens. Obstet Gynecol 87: 897-904, 1996.
2. Barnes S: The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res Treat 46: 169-179, 1997.
3. Barnes S and Peterson TG: Biochemical targets of the isoflavone genistein in tumor cell lines. Proc Soc Exp Biol Med 208; 103-108, 1995.
4. DiPaola RS, Zhang H, Lambert G, Meeker R, Licitra E, Rafi MM, Zhu BT, Spaulding H, Goodin S, Toledano M, Hait W, Gallo M: Clinical and Biological activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. New England J Medicine 339: 785-791, 1998.
5. Robertson CN, Robertson KM, Padilla GM, O'Brien ET, Cook JM, Kim CS, Fine RL: Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells. J Natl Cancer Inst 88: 908-917, 1996.
6. Citrin DL, Kies MS, Wallemark C, Khandekar J, Kaplan E, Camacho F and Lind R: A phase II study of high dose estrogen (Diethylstilbestrol Diphosphate) in prostate cancer. Cancer 56: 456-460, 1985.
7. Kameda H, Small EJ, Reese DM, Correy M, Frohich MA, Bok RA, Kelly W: A phase II study of PC-SPES, an herbal compound, for the treatment of advanced prostate cancer (Pea). Proc Amer Soc Clinical Oncology 18: 12-30, 1999.
8. Shibata S: Anti-tumorigenic Chalcones. Stem Cells 12: 44-52, 1994.
9. DeVincenzo R, Scambia G, Benedetti PP, Ranelletti FO, Bonanno G, Ercoli A, Delle Monache F, Ferrari F, Piantelli M and Mancuso S: Effect of synthetic and naturally occurring chalcones on ovarian cancer cell growth: structure-activity relationships. Anticancer Drug Des 10: 481-490, 1995.
10. Zhai L, Blom J, Chen M, Christensen SB and Kharazmi A: The antileishmanial agent Licochalcone A Interfers with the function of parasite mitochondria. Antimicrobial Agents and Chemotherapy 39: 2742-2748, 1995.
11. Shibata S, Inoue H, Iwata S, Ma R, Yu L, Ueyama H, Takayasu J, Hasegawa T, Tokuda H, Nishino A, Nishino H and Iwashima A: Inhibitory effects of licochalcone A isolated from Glycyrrhiza inflata root on inflammatory ear edema and tumour promotion in mice. Planta Med 57: 221-224, 1991.
12. Attalla H, Westberg JA, Andersson LC, Adlercreutz H and Makela TP: 2-Methoxyestradiol-induced phosphorylation of bcl-2: uncoupling from JNK/SAPK activation. Biochem Biophys Res Commun 29; 616-619, 1998.
13. Horvath G, Leser G, Karlsson L and Delle U: Estradiol regulates tumor growth by influencing p53 and bcl-2 expression in human endometrial adenocarcinomas grown in nude mice. In Vivo 10: 411-416, 1996.
14. Hadlar S, Chintapalli J and Croce CM: Taxol induces bcl-2 Phosphorylation and death of prostate cancer cells. Cancer Res 56: 1253, 1996.
15. Adam L, Crepin M and Israel L: Tumor growth inhibition, apoptosis, and bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination. Cancer Research 57: 1023-1029, 1997.
16. Gringrich JR, Tucker JA, Walther PJ, Day JW, Poulton SH and Webb KS: Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1). J Urol 146: 915-919, 1991.
17. Wang TTY and Phang JM: Effects of Estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55: 2487-2489, 1995.